These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 21345699

  • 1. Efficacy and safety of hydroxyethyl starch 6% 130/0.4 in a balanced electrolyte solution (Volulyte) during cardiac surgery.
    Base EM, Standl T, Lassnigg A, Skhirtladze K, Jungheinrich C, Gayko D, Hiesmayr M.
    J Cardiothorac Vasc Anesth; 2011 Jun; 25(3):407-14. PubMed ID: 21345699
    [Abstract] [Full Text] [Related]

  • 2. Changes in acid-base, electrolyte and hemoglobin concentrations during infusion of hydroxyethyl starch 130/0.42/6 : 1 in normal saline or in balanced electrolyte solution in children.
    Sümpelmann R, Witt L, Brütt M, Osterkorn D, Koppert W, Osthaus WA.
    Paediatr Anaesth; 2010 Jan; 20(1):100-4. PubMed ID: 19968805
    [Abstract] [Full Text] [Related]

  • 3. Volume replacement therapy during major orthopedic surgery using Voluven (hydroxyethyl starch 130/0.4) or hetastarch.
    Gandhi SD, Weiskopf RB, Jungheinrich C, Koorn R, Miller D, Shangraw RE, Prough DS, Baus D, Bepperling F, Warltier DC.
    Anesthesiology; 2007 Jun; 106(6):1120-7. PubMed ID: 17525586
    [Abstract] [Full Text] [Related]

  • 4. Volume replacement with a balanced hydroxyethyl starch (HES) preparation in cardiac surgery patients.
    Boldt J, Mayer J, Brosch C, Lehmann A, Mengistu A.
    J Cardiothorac Vasc Anesth; 2010 Jun; 24(3):399-407. PubMed ID: 20510247
    [Abstract] [Full Text] [Related]

  • 5. Hydroxyethyl starch 130/0.42/6:1 for perioperative plasma volume replacement in 1130 children: results of an European prospective multicenter observational postauthorization safety study (PASS).
    Sümpelmann R, Kretz FJ, Luntzer R, de Leeuw TG, Mixa V, Gäbler R, Eich C, Hollmann MW, Osthaus WA.
    Paediatr Anaesth; 2012 Apr; 22(4):371-8. PubMed ID: 22211931
    [Abstract] [Full Text] [Related]

  • 6. Hemostatic and electrolyte effects of hydroxyethyl starches in patients undergoing posterior lumbar interbody fusion using pedicle screws and cages.
    Choi SJ, Ahn HJ, Chung SS, Kim MH, Choi DH, Lee SM, Kang JG, Kim JK.
    Spine (Phila Pa 1976); 2010 Apr 01; 35(7):829-34. PubMed ID: 20072091
    [Abstract] [Full Text] [Related]

  • 7. A total balanced volume replacement strategy using a new balanced hydoxyethyl starch preparation (6% HES 130/0.42) in patients undergoing major abdominal surgery.
    Boldt J, Schöllhorn T, Münchbach J, Pabsdorf M.
    Eur J Anaesthesiol; 2007 Mar 01; 24(3):267-75. PubMed ID: 17054812
    [Abstract] [Full Text] [Related]

  • 8. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M, Plank C, Meissner U, Eberle KP, Weyand M, Cesnjevar R, Dötsch J, Rascher W.
    Pediatrics; 2006 Jul 01; 118(1):e76-84. PubMed ID: 16751617
    [Abstract] [Full Text] [Related]

  • 9. Rapidly degradable hydroxyethyl starch solutions impair blood coagulation after cardiac surgery: a prospective randomized trial.
    Schramko AA, Suojaranta-Ylinen RT, Kuitunen AH, Kukkonen SI, Niemi TT.
    Anesth Analg; 2009 Jan 01; 108(1):30-6. PubMed ID: 19095827
    [Abstract] [Full Text] [Related]

  • 10. Coagulation and biochemical effects of balanced salt-based high molecular weight vs saline-based low molecular weight hydroxyethyl starch solutions during the anhepatic period of liver transplantation.
    Ahn HJ, Yang M, Gwak MS, Koo MS, Bang SR, Kim GS, Lee SK.
    Anaesthesia; 2008 Mar 01; 63(3):235-42. PubMed ID: 18289228
    [Abstract] [Full Text] [Related]

  • 11. Effects of hypertonic saline (7.5%) on extracellular fluid volumes compared with normal saline (0.9%) and 6% hydroxyethyl starch after aortocoronary bypass graft surgery.
    Järvelä K, Koskinen M, Kaukinen S, Kööbi T.
    J Cardiothorac Vasc Anesth; 2001 Apr 01; 15(2):210-5. PubMed ID: 11312481
    [Abstract] [Full Text] [Related]

  • 12. The intraoperative therapeutic equivalence of balanced vs saline-based 6% hydroxyethyl starch 130/0.4 and their influence on perioperative acid-base status and renal functions.
    Helmy A, Mukhtar A, Ahmed A, Sief NE, Hussein A.
    J Clin Anesth; 2016 Aug 01; 32():267-73. PubMed ID: 27290988
    [Abstract] [Full Text] [Related]

  • 13. Voluven, a lower substituted novel hydroxyethyl starch (HES 130/0.4), causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5.
    Langeron O, Doelberg M, Ang ET, Bonnet F, Capdevila X, Coriat P.
    Anesth Analg; 2001 Apr 01; 92(4):855-62. PubMed ID: 11273914
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of 10% HES 130/0.4 versus 10% HES 200/0.5 for plasma volume expansion in cardiac surgery patients.
    Ertmer C, Wulf H, Van Aken H, Friederich P, Mahl C, Bepperling F, Westphal M, Gogarten W.
    Minerva Med; 2012 Apr 01; 103(2):111-22. PubMed ID: 22513516
    [Abstract] [Full Text] [Related]

  • 15. Hydroxyethyl starch 130/0.42/6:1 for perioperative plasma volume replacement in children: preliminary results of a European Prospective Multicenter Observational Postauthorization Safety Study (PASS).
    Sümpelmann R, Kretz FJ, Gäbler R, Luntzer R, Baroncini S, Osterkorn D, Haeger MC, Osthaus WA.
    Paediatr Anaesth; 2008 Oct 01; 18(10):929-33. PubMed ID: 18647272
    [Abstract] [Full Text] [Related]

  • 16. Safety of HES 130/0.4 (Voluven(R)) in patients with preoperative renal dysfunction undergoing abdominal aortic surgery: a prospective, randomized, controlled, parallel-group multicentre trial.
    Godet G, Lehot JJ, Janvier G, Steib A, De Castro V, Coriat P.
    Eur J Anaesthesiol; 2008 Dec 01; 25(12):986-94. PubMed ID: 18492315
    [Abstract] [Full Text] [Related]

  • 17. Six percent hydroxyethyl starch 130/0.4 (Voluven®) versus 5% human serum albumin for volume replacement therapy during elective open-heart surgery in pediatric patients.
    Van der Linden P, De Villé A, Hofer A, Heschl M, Gombotz H.
    Anesthesiology; 2013 Dec 01; 119(6):1296-309. PubMed ID: 23934169
    [Abstract] [Full Text] [Related]

  • 18. Alteration of anion gap and strong ion difference caused by hydroxyethyl starch 6% (130/0.42) and gelatin 4% in children.
    Witt L, Osthaus WA, Jüttner B, Heimbucher C, Sümpelmann R.
    Paediatr Anaesth; 2008 Oct 01; 18(10):934-9. PubMed ID: 18811828
    [Abstract] [Full Text] [Related]

  • 19. Hydroxyethyl Starch 130/0.4 and the Risk of Acute Kidney Injury After Cardiopulmonary Bypass: A Single-Center Retrospective Study.
    Lagny MG, Roediger L, Koch JN, Dubois F, Senard M, Donneau AF, Hubert MB, Hans GA.
    J Cardiothorac Vasc Anesth; 2016 Aug 01; 30(4):869-75. PubMed ID: 26774199
    [Abstract] [Full Text] [Related]

  • 20. Prospective, randomized, controlled, double-blind, multi-center, multinational study on the safety and efficacy of 6% Hydroxyethyl starch (HES) sOlution versus an Electrolyte solutioN In patients undergoing eleCtive abdominal Surgery: study protocol for the PHOENICS study.
    Buhre W, de Korte-de Boer D, de Abreu MG, Scheeren T, Gruenewald M, Hoeft A, Spahn DR, Zarbock A, Daamen S, Westphal M, Brauer U, Dehnhardt T, Schmier S, Baron JF, De Hert S, Gavranović Ž, Cholley B, Vymazal T, Szczeklik W, Bornemann-Cimenti H, Soro Domingo MB, Grintescu I, Jankovic R, Belda J.
    Trials; 2022 Feb 22; 23(1):168. PubMed ID: 35193648
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.